Home Cart 0 Sign in  
X

[ CAS No. 4774-35-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4774-35-0
Chemical Structure| 4774-35-0
Chemical Structure| 4774-35-0
Structure of 4774-35-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4774-35-0 ]

Related Doc. of [ 4774-35-0 ]

Alternatived Products of [ 4774-35-0 ]

Product Details of [ 4774-35-0 ]

CAS No. :4774-35-0 MDL No. :MFCD01632117
Formula : C6H6N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :KFWOVXLWAGKILN-UHFFFAOYSA-N
M.W : 154.12 Pubchem ID :11744833
Synonyms :

Calculated chemistry of [ 4774-35-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.33
TPSA : 72.31 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.83 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.22
Log Po/w (XLOGP3) : 0.58
Log Po/w (WLOGP) : -0.03
Log Po/w (MLOGP) : -0.63
Log Po/w (SILICOS-IT) : 0.26
Consensus Log Po/w : 0.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.43
Solubility : 5.69 mg/ml ; 0.0369 mol/l
Class : Very soluble
Log S (Ali) : -1.67
Solubility : 3.28 mg/ml ; 0.0213 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.14
Solubility : 11.2 mg/ml ; 0.0728 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.48

Safety of [ 4774-35-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4774-35-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 4774-35-0 ]

[ 4774-35-0 ] Synthesis Path-Downstream   1~18

  • 1
  • [ 4774-35-0 ]
  • [ 85118-01-0 ]
  • [ 1204400-22-5 ]
YieldReaction ConditionsOperation in experiment
89% Method of svnthesising A.25Sodium hydride (60 %; 1.40 g, 36.0 mmol) is placed in DMF (70 mL), mixed with carboxylic acid ester A.a.1 (5.00 g, 32.0 mmol) and stirred for 45 min at 20C. Then benzylbromide A.b.1 (4.10 mL, 32.0 mmol) is metered in and the mixture is stirred for a further 3 h at 20C. The reaction mixture is combined with HCI (50 mL, 1 N) and DCM (50 mL), the organic phase is separated off and extracted again with HCI (2 x 30 mL). Then the organic phase is dried, the solvent is eliminated in vacuo and carboxylic acid ester A*.25 (10.0 g, 89 %; HPLC-MS: MS(M+H)+ = 281 ; tRel = 1 .57 min; method FEC3) is obtained.
89% Sodium hydride (60 %; 1.40 g, 36.0 mmol) is placed in DMF (70 mL), carboxylic acid ester A.a.1 (5.00 g, 32.0 mmol) is added and the mixture is stirred for 45 min at 20C. Then benzylbromide A.b.1 (4.10 mL, 32.0 mmol) is metered in and the mixture is stirred for a further 3 h at 20C. The reaction mixture is combined with HCI (50 mL, 1 N) and DCM (50 mL), the organic phase is separated off and extracted again with HCI (2 x 30 mL). Then the organic phase is dried, the solvent is eliminated in vacuo and carboxylic acid ester A*.32 (10.0 g, 89 %; HPLC-MS: MS(M+H)+ = 281 ; = 1.57 min; method FEC3) is obtained.
89% Method of Synthesising A.25Sodium hydride (60%; 1.40 g, 36.0 mmol) is placed in DMF (70 mL), mixed with carboxylic acid ester A.a.1 (5.00 g, 32.0 mmol) and stirred for 45 min at 20 C. Then benzylbromide A.b.1 (4.10 mL, 32.0 mmol) is metered in and the mixture is stirred for a further 3 h at 20 C. The reaction mixture is combined with HCl (50 mL, 1 N) and DCM (50 mL), the organic phase is separated off and extracted again with HCl (2×30 mL). Then the organic phase is dried, the solvent is eliminated in vacuo and carboxylic acid ester A*.25 (10.0 g, 89%; HPLC-MS: MS (M+H)+=281; tRet.=1.57 min; method FEC3) is obtained.Carboxylic acid ester A*.25 (1.9 g, 5.6 mmol) is taken up in MeOH (7.3 mL) and mixed with NaOH (6.2 mL, 1 M). After 16 h at 20 C. the mixture is diluted with water and extracted with DCM. The organic phase is discarded, the aqueous phase is acidified and extracted with DCM. The organic phase is dried on Na2SO4, filtered, the solvent is eliminated in vacuo and the free carboxylic acid A.25 (694 mg, 47%; HPLC-MS: MS (M+H)+=267; tRet.=0.29 min; method FECB4) is obtained.
a) Synthesis of free cyclic carboxylic acids A.1; Method for svnthesising A. Ia; Sodium hydride (60 %; 28.6 mg, 0.714 mmol) is suspended in 1.5 rnL DMF, combined with carboxylic acid ester B.l-la (100 mg, 0.649 mmol) and stirred for 45 min at 20C. Benzyl bromide B.2a (134 mg, 0.649 mmol) is metered into the suspension and it is stirred for a further 3 h at 200C. The reaction mixture is combined with 1 N hydrochloric acid and DCM, the organic phase is separated off and extracted 2 x with 1 N hydrochloric acid. Then the organic phase is dried, the solvent is eliminated in vacuo and carboxylic acid ester A.l*a (HPLC-MS: tRet. = 1.50 min; MS(M+H)+ = 281; method FECB3) is obtained.

  • 4
  • [ 4774-35-0 ]
  • [ 1345437-63-9 ]
  • 5
  • [ 4774-35-0 ]
  • [ 1345437-78-6 ]
  • 6
  • [ 4774-35-0 ]
  • [ 1345438-94-9 ]
  • 7
  • [ 4774-35-0 ]
  • [ 1345447-32-6 ]
  • 8
  • [ 4774-35-0 ]
  • [ 1345438-96-1 ]
  • 9
  • [ 4774-35-0 ]
  • [ 1345439-02-2 ]
  • 10
  • [ 4774-35-0 ]
  • [ 1345439-22-6 ]
  • 11
  • [ 4774-35-0 ]
  • [ 1345439-39-5 ]
  • 12
  • [ 4774-35-0 ]
  • [ 1345440-61-0 ]
  • 13
  • [ 4774-35-0 ]
  • [ 1345447-34-8 ]
  • 14
  • [ 4774-35-0 ]
  • [ 1345447-36-0 ]
  • 15
  • [ 4774-35-0 ]
  • [ 1345447-38-2 ]
  • 16
  • [ 4774-35-0 ]
  • [ 1345447-40-6 ]
  • 17
  • [ 4774-35-0 ]
  • [ 1345440-66-5 ]
  • 18
  • [ 4774-35-0 ]
  • [ 1350731-65-5 ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4774-35-0 ]

Alcohols

Chemical Structure| 15400-53-0

[ 15400-53-0 ]

Ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 38324-83-3

[ 38324-83-3 ]

2-Hydroxypyrimidine-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 397308-78-0

[ 397308-78-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carboxylic acid

Similarity: 0.74

Chemical Structure| 4786-53-2

[ 4786-53-2 ]

4-Hydroxypyrimidine-5-carboxamide

Similarity: 0.73

Chemical Structure| 20187-46-6

[ 20187-46-6 ]

Ethyl 4-amino-2-hydroxypyrimidine-5-carboxylate

Similarity: 0.73

Esters

Chemical Structure| 15400-53-0

[ 15400-53-0 ]

Ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 15400-58-5

[ 15400-58-5 ]

Methyl 2,4-dimethoxypyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 308348-93-8

[ 308348-93-8 ]

Methyl 2-aminopyrimidine-5-carboxylate

Similarity: 0.81

Chemical Structure| 57401-76-0

[ 57401-76-0 ]

Ethyl 2-aminopyrimidine-5-carboxylate

Similarity: 0.78

Chemical Structure| 65195-35-9

[ 65195-35-9 ]

Ethyl 4-aminopyrimidine-5-carboxylate

Similarity: 0.78

Related Parent Nucleus of
[ 4774-35-0 ]

Pyrimidines

Chemical Structure| 72411-89-3

[ 72411-89-3 ]

4-Methoxypyrimidine-5-carboxylic acid

Similarity: 0.97

Chemical Structure| 15400-53-0

[ 15400-53-0 ]

Ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 15400-58-5

[ 15400-58-5 ]

Methyl 2,4-dimethoxypyrimidine-5-carboxylate

Similarity: 0.86

Chemical Structure| 23945-44-0

[ 23945-44-0 ]

2,4-Dihydroxypyrimidine-5-carboxylic acid

Similarity: 0.84

Chemical Structure| 4595-61-3

[ 4595-61-3 ]

Pyrimidine-5-carboxylic acid

Similarity: 0.82